Why Not Use Oral S-1 in Colon Cancer?

Dr David Kerr reports that S-1, an oral fluoropyrimidine used as adjuvant therapy in stage III colon cancer, is noninferior to a 3-drug regimen, suggesting that S-1 is a strong option in this setting.

Source: Medscape Gastroenterology Podcast - November 3, 2014 Category: Gastroenterology Authors: Medscape Source Type: podcasts